Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
Houhui Shi, Kai Li, Yanghong Ni, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The Hippo signalling pathway and its implications in human health and diseases
Minyang Fu, Yuan Hu, Tianxia Lan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 324
Fibronectin-Coated Metal–Phenolic Networks for Cooperative Tumor Chemo-/Chemodynamic/Immune Therapy via Enhanced Ferroptosis-Mediated Immunogenic Cell Death
Yao‐Zhong Xu, Yunqi Guo, Changchang Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 1, pp. 984-996
Closed Access | Times Cited: 143
Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 132
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment
Dimitrios N. Sidiropoulos, Christine I. Rafie, Julie K. Jang, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 656-669
Open Access | Times Cited: 49
Trained immunity: Target for prophylaxis and therapy
Athanasios Ziogas, Mariolina Bruno, Roy van der Meel, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 11, pp. 1776-1791
Open Access | Times Cited: 28
Advances in adoptive T-cell therapy for metastatic melanoma
Aparimita Das, Aruni Ghose, Kevin Naicker, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 3, pp. 103404-103404
Closed Access | Times Cited: 21
Current status and future of cancer vaccines: A bibliographic study
Rui Yu, Fangmin Zhao, Zeting Xu, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24404-e24404
Open Access | Times Cited: 7
Recent Findings on Therapeutic Cancer Vaccines: An Updated Review
Sara Sheikhlary, David Humberto Lopez, Sophia Moghimi, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 503-503
Open Access | Times Cited: 7
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Rare Adverse Events of CAR T-Cell Therapy
A Müller, Federico Simonetta
healthbook TIMES Oncology Hematology (2024), Iss. 19
Open Access | Times Cited: 4
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Advances in Antibody-Based Immune-Stimulating Drugs: Driving Innovation in Cancer Therapy
R R Zhao, Xing-Xing Fan
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1440-1440
Open Access
Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
Juan F. Santibáñez
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Mechanistic insights into resistance mechanisms to T cell engagers
Liping Cao, Gabrielle Leclercq-Cohen, Christian Klein, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
Junfeng Liu, Raziye Piranlioglu, Fei Ye, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors
Rohulla Vaseq, Amit Sharma, Yutao Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5626-5626
Open Access | Times Cited: 7
Advancing Cancer Treatment Through Nanotechnology Driven Immunotherapy for Pancreatic Cancer
Sreejith Thrivikraman Nair, Kaladhar Kamalasanan, Smarakan Sneha, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 20, pp. 18670-18697
Closed Access | Times Cited: 7
Metabolism Shapes Immune Responses to <i>Staphylococcus aureus</i>
Prabhakar Arumugam, Tammy Kielian
Journal of Innate Immunity (2023) Vol. 16, Iss. 1, pp. 12-30
Open Access | Times Cited: 7
Myeloid-derived suppressor cells and vaccination against pathogens
Estefanía Prochetto, Eliana Borgna, Carlos Jiménez‐Cortegana, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 10
Understanding immune checkpoints and PD-1/PD-L1-mediated immune resistance towards tumour immunotherapy
S. D. Singh, Navneet Singh, Manoj Baranwal, et al.
3 Biotech (2023) Vol. 13, Iss. 12
Open Access | Times Cited: 5
Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells
Oliver Goldmann, Eva Medina
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Targeting myeloid-derived suppressor cells to attenuate vasculogenic mimicry and synergistically enhance the anti-tumor effect of PD-1 inhibitor
Yinan Li, Kailiang Qiao, Xiaoyun Zhang, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103392-103392
Open Access | Times Cited: 10
Bojungikki-Tang Enhances the Effect of PD-1 Blockade in a Syngeneic Murine Model of Lung Carcinoma
Jaemoo Chun, Han Na Kang, Jin-Mu Yi, et al.
Processes (2022) Vol. 10, Iss. 9, pp. 1683-1683
Open Access | Times Cited: 4
Amplifying Glioblastoma Immunotherapy: T Cell Shielding through Nitric Oxide/Reactive Oxygen Species Scavenging Nanoparticles Potentiates anti-PD-1
Jihye Lee, Yeoul Kang, Hyori Lee, et al.
Biomaterials (2024) Vol. 315, pp. 122904-122904
Closed Access
Navigating the Immune Maze: Pioneering Strategies for Un-shackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
(2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top